Australia Allows Substitution of Biosimliar for Etanercept Brand

Published date26 August 2016
Law FirmGoodwin
Subject MatterBiosimilars,Commercial Bankruptcy,Pharmaceutical Patents,Australia
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT